Literature DB >> 10468087

Elevated levels of C-reactive protein before coronary artery bypass grafting predict recurrence of ischemic events.

D Milazzo1, L M Biasucci, N Luciani, L Martinelli, C Canosa, R Schiavello, A Maseri, G Possati.   

Abstract

C-reactive protein was measured in 86 patients undergoing coronary artery bypass graft surgery. Patients were followed up for 3.2 years (range 1 to 6). Patients with C-reactive protein > or = 3 mg/L had significantly increased risk of recurrent ischemia at 1 to 6 years after intervention.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10468087     DOI： 10.1016/s0002-9149(99)00333-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  11 in total

Review 1.  Regular review: treatment possibilities for unstable angina.

Authors:  A Manhapra; S Borzak
Journal:  BMJ       Date:  2000-11-18

2.  Plateletcrit. A platelet marker associated with saphenous vein graft disease.

Authors:  I Akpinar; M R Sayin; Y C Gursoy; T Karabag; E Kucuk; M C Buyukuysal; M Aydin; I C Haznedaroglu
Journal:  Herz       Date:  2013-04-12       Impact factor: 1.443

3.  Inflammatory markers as prognostic factors of recurrence in advanced-stage squamous cell carcinoma of the head and neck.

Authors:  M Valdes; J Villeda; H Mithoowani; T Pitre; M Chasen
Journal:  Curr Oncol       Date:  2020-06-01       Impact factor: 3.677

4.  Hypercholesterolemia and Dyslipidemia: Issues for the Clinician.

Authors:  H. Robert Superko; Nicolas A. Chronos
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-02

5.  Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery.

Authors:  Christopher D Owens; Paul M Ridker; Michael Belkin; Allen D Hamdan; Frank Pomposelli; Frank Logerfo; Mark A Creager; Michael S Conte
Journal:  J Vasc Surg       Date:  2006-11-21       Impact factor: 4.268

6.  Targeting C-reactive protein levels using high-dose atorvastatin before coronary artery bypass graft surgery.

Authors:  Norberto Krivoy; Zvi Adler; Ronen Saloma; Ashraf Hawadie; Zaher S Azzam
Journal:  Exp Clin Cardiol       Date:  2008

7.  Biomarkers of chronic inflammatory state in uremia and cardiovascular disease.

Authors:  Vincenzo Panichi; Alessia Scatena; Massimiliano Migliori; Valentina Marchetti; Sabrina Paoletti; Sara Beati
Journal:  Int J Inflam       Date:  2012-06-04

8.  Is leukocytosis a predictor for recurrence of ischemic events after coronary artery bypass graft surgery? A cohort study.

Authors:  Farid Rashidi; Peiman Jamshidi; Marziah Kheiri; Shadi Ashrafizadeh; Amir Ashrafizadeh; Fatemeh Abdolalian; Fatemeh Mirzamohamadi
Journal:  ISRN Cardiol       Date:  2012-07-03

9.  Fibrinogen beta-chain -C148T polymorphism is associated with increased fibrinogen, C-reactive protein, and interleukin-6 in patients undergoing coronary artery bypass grafting.

Authors:  Ewa Wypasek; Ewa Stepien; Malgorzata Kot; Dariusz Plicner; Boguslaw Kapelak; Jerzy Sadowski; Anetta Undas
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

Review 10.  Metabolic biomarkers for predicting cardiovascular disease.

Authors:  Jana E Montgomery; Jeremiah R Brown
Journal:  Vasc Health Risk Manag       Date:  2013-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.